Combined Heart-Kidney Transplantation: The University of Wisconsin Experience

Journal of Heart and Lung Transplantation

Volumn 26, Issue 11, 2007, Pages 1119-1126

  Hermsen, Joshua L ^a   Nath, Dilip S ^a   Munoz del Rio, Alejandro ^a   Eickstaedt, Joshua B ^a   Wigfield, Christopher ^a   Lindsey, Joshua D ^a   Edwards, Niloo M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MEDICAL RESEARCH; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES;

ACADEMIC MEDICAL CENTERS; ADULT; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WISCONSIN;

EID: 36048934299     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.08.011     Document Type: Article

References (21)

1. Roger V.L., Weston S.A., Redfield M.M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004) 344-350
2. Bommer J. Prevalence and socio-economic aspects of chronic kidney disease. Nephrol Dial Transplant 17 suppl 11 (2002) 8-12
3. Muntner P., Coresh J., Powe N.R., et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 14 (2003) 1568-1577
4. Norman J.C., Brook M.I., Cooley D.A., et al. Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1 (1978) 1125-1127
5. Laufer G., Kocher A., Grabenwoger M., et al. Simultaneous heart and kidney transplantation as treatment for end-stage heart and kidney failure. Transplantation 64 (1997) 1129-1134
6. Vermes E., Kirsch M., Houel R., et al. Immunologic events and long term survival after combined heart and kidney transplantation: a 12-year single-center experience. J Heart Lung Transplant 20 (2001) 247
7. Leeser D.B., Jeevanandam V., Furukawa S., et al. Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant 1 (2001) 89-92
8. Trachiotis G.D., Vega J.D., Johnston T.S., et al. Ten-year follow-up in patients with combined heart and kidney transplantation. J Thorac Cardiovasc Surg 126 (2003) 2065-2071
9. Luckraz H., Parameshwar J., Charman S.C., et al. Short- and long-term outcomes of combined cardiac and renal transplantation with allografts from a single donor. J Heart Lung Transplant 22 (2003) 1318-1322
10. Audard V., Grimbert P., Kirsch M., et al. Successful combined heart and kidney transplantation in a patient with sickle-cell anemia. J Heart Lung Transplant 25 (2006) 993-996
11. Blanche C., Kamlot A., Blanche D.A., et al. Combined heart-kidney transplantation with single-donor allografts. J Thorac Cardiovasc Surg 122 (2001) 495-500
12. Narula J., Bennett L.E., DiSalvo T., et al. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation 63 (1997) 861-867
13. Castillo-Lugo J.A., and Brinker K.R. An overview of combined heart and kidney transplantation. Curr Opin Cardiol 14 (1999) 121-125
14. Madsen J.C., Superina R.A., Wood K.J., et al. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332 (1988) 161-164
15. Mezrich J.D., Sachs D.H., and Madsen J.C. Combined heart and kidney transplantation: are two organs better than one?. J Heart Lung Transplant 21 (2002) 714-716
16. Uber P.A., and Mehra M.R. Induction therapy in heart transplantation: is there a role?. J Heart Lung Transplant 26 (2007) 205-209
17. Groetzner J., Kaczmarek I., Mueller M., et al. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression. J Heart Lung Transplant 24 (2005) 1787-1792
18. Pinderski L.J., Kirklin J.K., McGiffin D., et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?. J Heart Lung Transplant 24 (2005) 1828-1833
19. Lubitz S.A., Pinney S., Wisnivesky J.P., et al. Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation. J Heart Lung Transplant 26 (2007) 264-272
20. Al Aly Z., Abbas S., Moore E., et al. The natural history of renal function following orthotopic heart transplant. Clin Transplant 19 (2005) 683-689
21. Rubel J.R., Milford E.L., McKay D.B., et al. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 23 (2004) 289-300